← FDA Drug Approvals (Drugs@FDA)

IMMPHENTIV

NDA · New Drug Application · Sponsor: HIKMA · Approved 2012-12-20

Drug application

FDA Application #

NDA203826

Application type

New Drug Application

Brand name

IMMPHENTIV

Generic name

PHENYLEPHRINE HYDROCHLORIDE

Active ingredients

PHENYLEPHRINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

HIKMA

Manufacturer

Hikma Pharmaceuticals USA Inc.

First approval

2012-12-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown